Media Call: COVID-19 Variant Guidances – 2/22/2021
Media Call: COVID-19 Variant Guidances – 2/22/2021
The FDA is scheduled to hold a media availability to discuss FDA policies issued today to guide vaccines, diagnostic and therapeutic developers addressing COVID-19 virus variants. The media call is scheduled for Feb. 22, 2021, at 1:40 p.m. EST. Acting FDA Commissioner Janet Woodcock, M.D. and other senior leaders will be taking questions.Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.